Bruce Berkowitz’s 10 Biggest Stock Bets for 2027

8. The Kraft Heinz Company (NYSE:KHC)

Fairholme Capital Management Equity Stake: $4.59 Million

Number of Hedge Fund Holders: 62

The Kraft Heinz Company (NYSE:KHC) is one of the dividend-paying consumer staples stocks in billionaire Bruce Berkowitz’s portfolio, supported by its portfolio of established brands, defensive business model, and potential turnaround opportunity. Its well-known brands, including Heinz, Kraft, and Lunchables, provide exposure to everyday consumer products that tend to maintain demand across different economic conditions.

The Kraft Heinz Company’s defensive characteristics make it particularly appealing to value-oriented investors seeking relatively stable cash flows and consistent shareholder distributions. However, its third-quarter 2026 results highlight the operational challenges it continues to face. Is Kraft Heinz stock Cheap?

Net sales declined 2% year over year to $6.1 billion, while organic sales fell 1.1% amid persistent volume and product mix pressures. Operating income also dropped 14.6%. Meanwhile, free cash flow for the first nine months of 2026 totaled $2.4 billion, representing a 5.2% decline from the prior-year period.

Amid the disappointing results, management has embarked on a turnaround plan with plans to return to organic sales growth in the second half of next year. The company is also targeting consistent growth and margin expansion by 2028.

Meanwhile, The Kraft Heinz Company continues to offer an attractive income proposition. The company pays a quarterly dividend of $0.40 per share, equivalent to $1.60 annually. It maintained this quarterly payout throughout 2023, 2024, 2025, and 2026, providing shareholders with a predictable income stream while management worked to improve the company’s operating performance.

7. Pfizer Inc. (NYSE:PFE)

Fairholme Capital Management Equity Stake: $6.58 Million

Number of Hedge Fund Holders: 83

Pfizer Inc. (NYSE:PFE) is one of the best stocks to buy according to billionaire Bruce Berkowitz because of its attractive dividend yield, established pharmaceutical portfolio, and oncology expansion. The company has also made significant efforts to rebuild revenue growth through its drug pipeline and offset declining revenue from COVID-19 products and patent expirations.

Pfizer Inc.’s efforts to diversify its revenue base beyond legacy COVID-19 products are beginning to gain traction. In the third quarter of 2026, the company generated $16.58 billion in revenue, while sales excluding Comirnaty and Paxlovid increased 7% operationally. Revenue from newly launched and acquired products grew 32% operationally, contributing approximately $3.8 billion to quarterly sales. This growth highlights the company’s progress in building new revenue streams to compensate for declining contributions from older products.

In addition to revenue growth, Pfizer continues to appeal to income-focused investors given its established dividend payment history. It returned $7.3 billion to shareholders through cash dividends during the first nine months of 2026, equivalent to $1.29 per share. Is PFE one of the best cancer stocks to invest in now?

The oncology business provides another important long-term growth opportunity. The acquisition of Seagen has strengthened Pfizer Inc.’s position in cancer treatment, particularly through antibody-drug conjugates (ADCs). The company also continues to invest heavily in research and development, having spent $8.3 billion through September to replenish its portfolio and reduce dependence on older medicines.

It is also working to improve operating efficiency through restructuring and manufacturing optimization programs. Its cost realignment program is expected to deliver approximately $6.7 billion in cumulative net cost savings through 2029.

6. The Progressive Corporation (NYSE:PGR)

Fairholme Capital Management Equity Stake: $14.96 Million

Number of Hedge Fund Holders: 87

The Progressive Corporation (NYSE:PGR) is one of the top insurance stocks in billionaire Bruce Berkowitz’s portfolio, supported by strong underwriting capabilities and competitive position in the US auto insurance market. The company’s ability to accurately assess risk and price policies has been central to its sustained underwriting profitability and growth.

In the third quarter of 2026, its combined ratio dropped to 88.7%, compared with 89.5% in the prior-year quarter. A ratio below 100% means an insurer collects more in premiums than it pays out in claims and underwriting expenses. Its underwriting profit margin reached 11.3%, significantly exceeding management’s long-term target of 4%.

The Progressive Corporation has demonstrated an ability to expand its customer base while maintaining underwriting profitability. Net premiums written increased 4% year over year in Q3 to $22.3 billion, while net premiums earned increased 5% to $21.87 billion. Meanwhile, total policies in force increased 6% to approximately 40.5 million, asserting continued demand for the company’s insurance products.

Net income in the quarter totaled $2.54 billion, allowing the company to generate substantial capital that can support business expansion, share repurchases, and dividend payments. During the first nine months of the year, it returned $1.6 billion to shareholders through stock buybacks. Take a closer look at Progressive’s (PGR) economic moat

The Progressive Corporation stands out as a long-term investment opportunity, combining premium growth, customer expansion, and consistent underwriting profitability in the competitive property and casualty insurance industry.

5. W. R. Berkley Corporation (NYSE:WRB)

Fairholme Capital Management Equity Stake: $17.31 Million

Number of Hedge Fund Holders: 46

W. R. Berkley Corporation (NYSE:WRB) is one of the best insurance stocks in billionaire Bruce Berkowitz’s portfolio, supported by its disciplined underwriting practices, strong capital position, and consistent profitability. The company’s focus on specialty insurance markets also provides an attractive investment opportunity, particularly given its ability to generate underwriting profits while maintaining solid returns on capital.

One of the company’s biggest competitive advantages is its ability to generate underwriting profits. The company’s underwriting discipline is reflected in its combined ratio. In the third quarter of 2026, its consolidated GAAP combined ratio was 90.8%, compared with 90.9% in the same quarter of 2025. Its accident-year combined ratio, excluding catastrophe losses, was even stronger at 88.1%. This demonstrates the underlying profitability of its insurance operations.

Additionally, W. R. Berkley Corporation continues to generate attractive returns on capital. In the third quarter of 2026, it achieved a return on equity of 18.4% with an operating return on equity of 18.8%. Operating income totaled $456.5 million. For the first nine months of 2026, operating income reached approximately $1.47 billion, up from $1.28 billion in the corresponding period of 2025.

W. R. Berkley Corporation has a substantial fixed-income investment portfolio that generates recurring income. Net investment income increased 9.2% to approximately $383.5 million in Q3. A robust capital allocation strategy also strengthens its investment appeal. During the first nine months of 2026, it returned approximately $728.6 million to shareholders, including $435.1 million in share repurchases.